Eurofins Scientific SE

OTC: ERFSF · Real-Time Price · USD
80.51
0.36 (0.45%)
At close: Aug 15, 2025, 11:57 AM

Eurofins Scientific SE Cash Flow Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
554.6M 310.2M 780M 1.06B
Depreciation & Amortization
596.9M 664.3M 504.4M 450.7M
Stock-Based Compensation
138.3M 137.7M 136.1M 131M
Other Working Capital
10.6M 16.7M 13.3M 14.6M
Other Non-Cash Items
-22.3M -60.6M -317.2M 176.9M
Deferred Income Tax
n/a n/a n/a -298.9M
Change in Working Capital
51.4M -33.7M 33M -6.6M
Operating Cash Flow
1.32B 1.02B 1.14B 1.51B
Capital Expenditures
-528.4M -550.1M -660.2M -519.5M
Cash Acquisitions
-344.3M -158.1M -214.7M -532.7M
Purchase of Investments
n/a n/a -1.5M -8.4M
Sales Maturities Of Investments
n/a n/a 1.5M 8.4M
Other Investing Acitivies
-48.6M -44.9M 19M 18M
Investing Cash Flow
-846.5M -681.1M -855.9M -1.03B
Debt Repayment
-359.7M 548.5M 551M -453.7M
Common Stock Repurchased
-271.9M -55.8M -15.8M -3.6M
Dividend Paid
-95.6M -233.9M -192.1M -129.7M
Other Financial Acitivies
-362.5M 337.5M -237.1M -359.1M
Financial Cash Flow
-1.09B 413.6M -311.3M -910.3M
Net Cash Flow
-607.7M 737.7M -31.8M -395.5M
Free Cash Flow
790.5M 467.8M 476.1M 990.3M